Artiva Biotherapeutics ARTV
NASDAQ ARTV
$6.20 -0.29 (-4.47%)
At close: Oct 22, 2026 · 4:00 PM EDT

Artiva Biotherapeutics (ARTV) Net Equity Issued and Repurchased (2024 - 2025)

Updated

Artiva Biotherapeutics (ARTV) reported Net Equity Issued and Repurchased of $138,000 for FY2025, down 99.9% from $166.51 million in FY2024.

Analysis

Artiva Biotherapeutics (ARTV) Net Equity Issued and Repurchased (2024 - 2025) Analysis & Trends

  • According to Business Quant data, Net Equity Issued and Repurchased came in at $166.51 million in FY2024 and $10,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -966.00 Mn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -9.00 Mn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 6.00 Mn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -346.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Artiva Biotherapeutics 244.36 Mn -105.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 138,000.00
Dec 31, 2024 23,000.00
Sep 30, 2024 166.51 Mn
API Access

Artiva Biotherapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ARTV&period=max&api_key=YOUR_API_KEY